A Study to Determine Pharmacokinetic Characteristics of LY03010 Versus INVEGA SUSTENNA® in Schizophrenia Patients

Clinical trial NCT03751488 · COMPLETED

Trial details

NCT number: NCT03751488
Sponsor: Luye Pharma Group Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Schizo Affective Disorder Schizophrenia Schizoaffective Disorder

Start date: 2018-12-12
Primary completion: 2019-07-24
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.